Stock Events

Stock Events

Search...

Allogene Therapeutics (ALLO) Q2 2026 Earnings

6MayConfirmed

Q3 2025

Q4 2025

Q1 2026

Next

-0.27

-0.24

-0.2

-0.17

Details

Expected EPS

-0.188338

Actual EPS

N/A

Surprise EPS

0.19

Surprise Percent

+100%

Description

Allogene Therapeutics (ALLO) will report earnings of for Q2 2026 on May 06, 2026.

0 Comments

Share your thoughts

Get the Stock Events App

Sign up for a Stock Events account to create your own watchlists and track your portfolio or dividends.